BioDrugs

1.5k papers and 33.5k indexed citations i.

About

The 1.5k papers published in BioDrugs in the last decades have received a total of 33.5k indexed citations. Papers published in BioDrugs usually cover Immunology (465 papers), Molecular Biology (344 papers) and Oncology (299 papers) specifically the topics of Biosimilars and Bioanalytical Methods (211 papers), Monoclonal and Polyclonal Antibodies Research (176 papers) and Rheumatoid Arthritis Research and Therapies (93 papers). The most active scholars publishing in BioDrugs are William R. Strohl, Anna Mero, Francesco M. Veronese, Gillian M. Keating, Jeremy P. Bradshaw, Serge Muyldermans, Ivana Jovčevska, Roland E. Kontermann, Michael Naso and Brian Tomkowicz.

In The Last Decade

Fields of papers published in BioDrugs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in BioDrugs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in BioDrugs.

Countries where authors publish in BioDrugs

Since Specialization
Citations

This map shows the geographic impact of research published in BioDrugs. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in BioDrugs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites BioDrugs more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore journals with similar magnitude of impact

Rankless by CCL
2025